Navigation Links
Veterans for America's (VFA) Wounded Warrior Outreach Program Responds to Fort Drum in Aftermath of Report
Date:2/21/2008

WASHINGTON, Feb. 21 /PRNewswire-USNewswire/ -- Veterans for America looks forward to continuing to work with leaders at Fort Drum as well as others in the U.S. Army to improve post-combat mental health care for our country's Soldiers.

The members of the 2nd BCT of the 10th Mountain Division have endured great hardship for all of us. Unfortunately, neither the Army nor the country at large was prepared to adequately address the great post-combat mental health burden created by our wars in Afghanistan and Iraq.

The 2nd BCT is the most heavily used brigade in the U.S. Army, having been deployed four times in the six years after 9/11. The Army has reported that with each additional tour a service member's likelihood of having post-combat mental health problems increases by 60 percent. Members of the 2nd BCT were more than five times more likely to be killed than the average of all others who have been deployed.

Veterans for America applauds the steps that have been taken by Fort Drum's leaders to devote more resources to meeting the considerable post-combat mental health needs of Soldiers in the 2nd BCT. Hiring more permanent staff is a positive step. Bringing additional professionals from Walter Reed Army Medical Center is also laudable. But these Walter Reed-based professionals will return home after spending a few weeks or months in the North Country and recruiting qualified mental health professionals to work on base will continue to be a challenge.

Leaders at Fort Drum should know that they are not alone in this struggle. Creating a world-class system of treatment for post-combat mental health issues for Soldiers is a great national challenge.

According to Bobby Muller, President of Veterans for America, "While Veterans for America was not able to interview all the members of the 2nd BCT, it is clear to us that many Soldiers -- certainly more than those with whom we spoke -- are suffering greatly as a result of in
'/>"/>

SOURCE Veterans for America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. McCain Myth Buster Day 3: John McCain and Veterans Health Care
2. Veterans Organizations Call for Lung Cancer Screening
3. Veterans for America Wounded Warrior Outreach Program
4. Easter Seals Launches Nationwide Program for U.S. Service Members and Veterans Deployed to Iraq or Afghanistan with Traumatic Brain Injury
5. NHPC tackles escalating health care costs, veterans health, comparative effectiveness research
6. Mental health linked to amputation risk in diabetic veterans
7. Predicting post-traumatic stress disorders in deployed veterans
8. EEG Institute to Provide Free Post-Traumatic Stress Treatment for Iraq and Afghanistan Veterans
9. Knights Distribute $1 Million Worth of Wheelchairs to Veterans
10. Non-Profit Calls on Mental Health Professionals to Honor Veterans Day by Giving an Hour of Free Counseling to Returning Veterans
11. Report Release: Veterans for America Finds Care for PTSD and TBI Inadequate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...ire-USNewswire/ -- The University of Texas M. D....collaborative effort to eradicate breast cancer in...Awareness and Research of the Americas today at an...ed States, and Vivian Fernandez de Torrijos, the F...rson in the initiative are the U.S. Department of ...
(Date:11/21/2008)...PRNewswire-USNewswire/ -- U.S. News & World Re...nce (NCQA) ranked BlueChoice(R) HealthPlan of Sout...th Plans(TM), published in U.S. News & World R...annual ranking ranks the nation,s best health plan...nd NCQA accreditation scores. NCQA and U.S. News &...
(Date:11/21/2008)...gs do not cause genetic damage that can lead to di...s) -- Two popular medications for treating attenti...use genetic damage linked to an increased risk for...dy, done by researchers at Duke University Medical...nters a previous one that reported biomarkers asso...
(Date:11/21/2008)...swire/ -- For the second year in a row and the t...are Worldwide,s agency network won more creative a...nual international RX Club Show. , , Nine ...otal of 59 RX Club Awards of Excellence, including...are Worldwide agencies include Caudex Medical, ech...
Breaking Medicine News(10 mins):Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:ADHD Medications Don't Pose Cancer Risk 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 2Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 3Health News:McCann Healthcare Worldwide Agencies Again Win Most Awards at RX Club Show 2008 4
...arch UK survey reveals today. Over a quarter of Br...g the list over Alzheimer’s,// heart attack and te...s that the majority don’t realize approximately ho...ted by lifestyle factors. While two thirds of peop...
...roduced a bill (HR 1943) that would require federa... beginning and end of their// incarcerations, CQ H...ederal prisons to provide inmates with HIV/AIDS co... would receive access to comprehensive treatment. ...
...ody in the United Kingdom is suffering a stroke? I...kes could have been averted with// timely blood pr...ng one in four people due to undetected blood pres... Stroke Association studied blood pressure reading...
...tified the first patient-to-patient transmission o...rgery, despite standard infection// control proced...een published in the Journal of Infectious Disease...d an accompanying editorial say the case reinforce...
Other Medicine News:Health News:Survey Shows That Most People Unaware About Cancer Prevention 2Health News:Despite Control Efforts HBV Found to Transmit After Dental Surgery 2
(Date:11/21/2008)... 21 Ikaria Holdings, Inc. today an...the Year by the New Jersey Technology Council (NJT...ovides business support, networking opportunities,... and their leaders. Ikaria earned the award based ... product/service provision. , , "We are del...
(Date:11/20/2008)... LINE RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIF...ROVEMENT IN DAILY FUNCTION, IN, ...Calif., and BRUSSELS, Belgium, Nov. 20 /PRNewswire...: JAZZ ) and UCB (Euronext Brussels: UCB),annou...rom the first of two,Phase III pivotal clinical t...
(Date:11/20/2008)...ov. 20 Radius Health ("Radius") an... million to its second institutional financing rou...million and the total amount raised since the comp...stitutional investors participated in the financin...ing MPM Capital, The Wellcome Trust, HealthCare Ve...
(Date:11/19/2008)...f., Nov. 19 Amgen,(Nasd...ompany, a subsidiary of,Takeda Pharmaceutical Com...rollment in the Phase 3 MONET1 trial evaluating mo...and carboplatin for the first-line treatment of,a...n temporarily suspended,following a planned safet...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Lumping different countries together why the 2008 EPI is of limited use 13136 1Lumping different countries together why the 2008 EPI is of limited use 13136 2Lumping different countries together why the 2008 EPI is of limited use 13136 3TU Delft tests windmill for seawater desalination 13134 1TU Delft tests windmill for seawater desalination 13134 2Local Emergency Preparedness Efforts Focus on Community Based Organizations 13132 1Local Emergency Preparedness Efforts Focus on Community Based Organizations 13132 2Kentucky Based Sports Medicine Duo Invited to Astros Spring Training Camp 13130 1Kentucky Based Sports Medicine Duo Invited to Astros Spring Training Camp 13130 2
...BRIDGE, Mass.--(BUSINESS WIRE)--Apr 12, 2007 - Dya...line results from its,Phase 3, placebo-controlled ...8 (ecallantide), for hereditary angioedema (HAE). ...uled for Tuesday,April 17, 2007 at 12:30 p.m. ET....asma kallikrein,inhibitor, is in clinical trials f...
...CELONA, Spain--(BUSINESS WIRE)--Apr 14, 2007 - In ...ting of the European Association,for the Study of ...,from a planned interim analysis of the PROVE 1 cl... short-duration therapy with,the investigational h...950) in combination with pegylated interferon (peg...
Other Medicine Technology:DX-88 for Hereditary Angioedema Meets Primary and Secondary,Endpoints in Phase 3 Trial (EDEMA3) 2DX-88 for Hereditary Angioedema Meets Primary and Secondary,Endpoints in Phase 3 Trial (EDEMA3) 3DX-88 for Hereditary Angioedema Meets Primary and Secondary,Endpoints in Phase 3 Trial (EDEMA3) 4DX-88 for Hereditary Angioedema Meets Primary and Secondary,Endpoints in Phase 3 Trial (EDEMA3) 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 2Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 3Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 4Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 5Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 6Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 7Interim Results Presented at EASL from PROVE 1 Clinical Trial of,Investigational Drug Telaprevir in Patients with Genotype 1,Hepatitis C 8
The ANGIO CT MIYABI system is a combination of a Siemens SOMATOM CT scanner on rails (Sliding Gantry) and an AXIOM Multistar angiography unit. Both systems use the KOORDINAT M angio table, which can
...iac workflow through Xper: a unique workflow conce...r settings. In addition Xper integrates all functi...ce. For example the interventional tools Allura 3D...ableside.,The excellent image quality and low...
...ptal repair implant. It differs from the CardioSEA...nism, fabricated from a single nitinol coil micro-...g sides of the umbrella arm tips and provides a se...o centrally locate the implant within the defect. ...
...iverse range of patients suffering from glaucoma, ...isease. Compact, Space Saving Design - Its compact...essionals to use the system in office, clinic, and...wer consumption is saved by controlling the power ...
Medicine Products: